NomosLogic
BIO2026 Partnership Opportunity
Back to Blog
BIO2026BIOInternationalGenomicsMultiOmicsPrecisionMedicineBiotechPharmaPartnershipsClinicalGenomicsPharmacogenomics

BIO2026 Partnership Opportunity

Matt HardyMay 27, 20261 min read

The calendar at BIO 2026 is already filling. Here's where NomosLogic plugs in.

NomosLogic is deterministic molecular medicine infrastructure. The foundational layer that turns molecular complexity into clinical clarity and commercial value.

San Diego Convention Center. June 22 to 25.

We want working conversations with partners across:

▸ Clinical Point of Care ▸ Consumer Genomics ▸ Payer Infrastructure ▸ Pharma Drug Discovery ▸ Sequencing Companies ▸ Diagnostics and Labs ▸ Category-scale Investors

If you operate in any of these surfaces and want to talk about where deterministic infrastructure plugs into your roadmap, DM me to lock 30 minutes during the conference.

Partnerships and BD: jai.dejong@nomoslogic.com

Strategic and CEO-level: matt.hardy@nomoslogic.com

MH

Matt Hardy

Published on May 27, 2026

NomosLogic is deterministic molecular medicine infrastructure. The foundational layer that turns molecular complexity into clinical clarity and commercial value.